European Institute of Oncology at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

European Institute of Oncology brings 1 presentation to AMP 2026 in Seattle. Its session covers liquid biopsy in advanced breast cancer, and what it takes to run rapid next-generation sequencing for biomarker assessment locally rather than sending samples away.

OrganizationAMP 2026 Attendance
Med centres
Comprehensive cancer center and research hospital in Milan.
Workshop
Wed, Nov 11
9:00am–9:50am
Bringing Liquid Biopsy Closer to Patients: Rapid Local NGS Testing for Biomarker Assessment in Advanced Breast Cancer
Running ctDNA testing locally for advanced breast cancer cuts turnaround, raising questions of validation, interpretation and quality control.
Workshop hosted by Pillar Biosciences

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from European Institute of Oncology

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction